Christine Fox
2023
In 2023, Christine Fox earned a total compensation of $1M as Chief Financial Officer at Mereo BioPharma Group plc, a 23% increase compared to previous year.
Compensation breakdown
| Bonus | $151,248 |
|---|---|
| Option Awards | $340,240 |
| Salary | $378,120 |
| Stock Awards | $91,043 |
| Other | $40,400 |
| Total | $1,001,051 |
Fox received $378.1K in salary, accounting for 38% of the total pay in 2023.
Fox also received $151.2K in bonus, $340.2K in option awards, $91K in stock awards and $40.4K in other compensation.
Rankings
In 2023, Christine Fox's compensation ranked 1,210th out of 2,983 executives tracked by ExecPay. In other words, Fox earned more than 59.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,210 out of 2,983 | 59th |
Division Manufacturing | 719 out of 1,637 | 56th |
Major group Chemicals And Allied Products | 483 out of 906 | 47th |
Industry group Drugs | 471 out of 869 | 46th |
Industry Pharmaceutical Preparations | 325 out of 627 | 48th |
Source: SEC filing on April 24, 2024.
Fox's colleagues
We found two more compensation records of executives who worked with Christine Fox at Mereo BioPharma Group plc in 2023.